fluphenazine depot has been researched along with Psychotic Disorders in 43 studies
fluphenazine decanoate : The prodrug of fluphenazine, an antipsychotic drug used for the symptomatic management of psychosis in patients with schizophrenia.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifty outpatients with schizophrenia or schizoaffective disorder were randomly assigned to receive 25 mg of fluphenazine decanoate intramuscularly either every 2 weeks or every 6 weeks for 54 weeks in a double-blind design." | 5.09 | Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks. ( Breier, AF; Buchanan, RW; Carpenter, WT; Kirkpatrick, B; Lann, HD; Summerfelt, AT, 1999) |
| "Forty-one patients with DSM-III schizophrenia or schizoaffective disorder were assigned to either adjunctive lithium or placebo after at least 6 months of fluphenazine decanoate treatment to stabilize symptoms had failed." | 5.09 | Lithium augmentation fails to reduce symptoms in poorly responsive schizophrenic outpatients. ( Glick, ID; Jacobs, M; Ninan, PT; Odbert, CL; Robinson, D; Schulz, SC; Thompson, PA; Weiden, PJ; Yadalam, K, 1999) |
| " All patients had been diagnosed as having schizophrenia or schizoaffective disorder, all were receiving stable doses of fluphenazine decanoate, and all had received benztropine mesylate in an attempt to rule out neuroleptic-induced akinesia." | 5.06 | Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial. ( Cooper, TB; Fagerstrom, R; Morgan, V; Rifkin, A; Siris, SG, 1987) |
| "The risk of adverse side effects of neuroleptic agents must be considered carefully in the treatment of acute and long-term psychotic states." | 3.75 | Antipsychotic drug side effects: their relationship to dose. ( Kane, JM, 1985) |
| "We examined the effect of age on psychopharmacological management in a naturalistic study of a group of 165 patients with a clinical diagnosis of schizophrenia or a related psychotic disorder (age range = 21-84 years; subjects > or = 1;45 years n = 86) treated with either haloperidol decanoate or fluphenazine decanoate." | 3.71 | The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders. ( Chengappa, KN; Jeste, DV; Mamo, DC; Reddy, RR; Sweet, RA, 2002) |
| "The future of depot neuroleptic therapy is discussed in terms of pharmacokinetic and pharmacodynamic research opportunities." | 2.37 | Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches. ( Davis, CM; Ereshefsky, L; Jann, MW; Richards, A; Saklad, SR; Seidel, DR, 1984) |
| " This means that it has a long half-life measurable in months rather than weeks." | 1.28 | Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration. ( Cooper, TB; Levinson, DF; Lo, ES; Simpson, GM; Stephanos, MJ; Yadalam, KG, 1990) |
| "Two cases of agranulocytosis occurring after addition of a butyrophenone to a course of phenothiazine treatment are reported and possible mechanisms for this interaction are discussed." | 1.28 | Two cases of agranulocytosis on addition of a butyrophenone to a long-standing course of phenothiazine treatment. ( Kehoe, R; Young, A, 1989) |
| "In a fatal case of neuroleptic malignant syndrome, a muscle sample taken within 1 h of death showed acute myopathic features with absence of muscle glycogen and neutral lipid." | 1.27 | Muscle pathology in the neuroleptic malignant syndrome. ( Martin, DT; Swash, M, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (72.09) | 18.7374 |
| 1990's | 7 (16.28) | 18.2507 |
| 2000's | 3 (6.98) | 29.6817 |
| 2010's | 2 (4.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nielssen, O | 1 |
| Fukui, A | 1 |
| Fawkner, L | 1 |
| Walker, K | 1 |
| Rajarethinam, R | 1 |
| Dziuba, J | 1 |
| Manji, S | 1 |
| Pizzuti, A | 1 |
| Lachover, L | 1 |
| Keshavan, M | 1 |
| Citrome, L | 1 |
| Jaffe, A | 1 |
| Levine, J | 1 |
| Mamo, DC | 1 |
| Sweet, RA | 1 |
| Chengappa, KN | 1 |
| Reddy, RR | 1 |
| Jeste, DV | 1 |
| Charles, J | 1 |
| Miller, G | 1 |
| Ng, A | 1 |
| Balon, R | 1 |
| Kabesh, Ia | 1 |
| Papezhova, G | 1 |
| Dencker, SJ | 1 |
| Ereshefsky, L | 2 |
| Saklad, SR | 2 |
| Jann, MW | 2 |
| Davis, CM | 2 |
| Richards, A | 1 |
| Seidel, DR | 1 |
| Glazer, WM | 1 |
| Kane, JM | 2 |
| Waldmann, KD | 1 |
| Neumann, J | 1 |
| Mattes, JA | 1 |
| Nayak, D | 1 |
| Polácek, J | 1 |
| Goode, DJ | 1 |
| Meltzer, HY | 1 |
| Fang, VS | 1 |
| Rektor, L | 1 |
| Blazek, J | 1 |
| Siris, SG | 9 |
| Bermanzohn, PC | 1 |
| Mason, SE | 1 |
| Shuwall, MA | 1 |
| Benazzi, F | 1 |
| Carpenter, WT | 1 |
| Buchanan, RW | 1 |
| Kirkpatrick, B | 1 |
| Lann, HD | 1 |
| Breier, AF | 1 |
| Summerfelt, AT | 1 |
| Schulz, SC | 1 |
| Thompson, PA | 1 |
| Jacobs, M | 1 |
| Ninan, PT | 1 |
| Robinson, D | 1 |
| Weiden, PJ | 1 |
| Yadalam, K | 1 |
| Glick, ID | 1 |
| Odbert, CL | 1 |
| Hoencamp, E | 1 |
| Haffmans, PJ | 1 |
| Jansen, GS | 1 |
| McClelland, HA | 1 |
| Metcalfe, AV | 1 |
| Kerr, TA | 1 |
| Dutta, D | 1 |
| Watson, P | 1 |
| Simpson, GM | 1 |
| Yadalam, KG | 1 |
| Levinson, DF | 1 |
| Stephanos, MJ | 1 |
| Lo, ES | 1 |
| Cooper, TB | 3 |
| Faraone, SV | 1 |
| Green, AI | 1 |
| Brown, W | 1 |
| Yin, P | 1 |
| Tsuang, MT | 1 |
| Young, A | 1 |
| Kehoe, R | 1 |
| Aronson, A | 2 |
| Sellew, AP | 1 |
| Adan, F | 3 |
| Cutler, J | 1 |
| Owen, K | 1 |
| Mason, S | 1 |
| Gingerich, S | 1 |
| Lang, MP | 1 |
| Teicher, MH | 1 |
| Baldessarini, RJ | 1 |
| Kolakowska, T | 1 |
| Williams, AO | 1 |
| Ardern, M | 1 |
| Van Putten, T | 1 |
| Marder, SR | 1 |
| Turns, DM | 1 |
| Pary, R | 1 |
| Tobias, CR | 1 |
| James, WA | 1 |
| Genz, A | 1 |
| Cohen, M | 1 |
| Mandeli, J | 2 |
| Casey, E | 2 |
| Strahan, A | 2 |
| Lee, A | 1 |
| Martin, DT | 1 |
| Swash, M | 1 |
| Munetz, MR | 1 |
| Ginchereau, EH | 1 |
| Toenniessen, LM | 1 |
| Morgan, V | 1 |
| Fagerstrom, R | 1 |
| Rifkin, A | 2 |
| Blum, A | 1 |
| Hinterhuber, H | 1 |
| Neumann, R | 1 |
| Reardon, GT | 1 |
| Doddi, SR | 1 |
| Hall, KS | 1 |
| Richards, AL | 1 |
| Burch, NR | 1 |
5 reviews available for fluphenazine depot and Psychotic Disorders
| Article | Year |
|---|---|
Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches.
Topics: Adult; Antipsychotic Agents; Biological Availability; Chromatography; Delayed-Action Preparations; F | 1984 |
Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches.
Topics: Adult; Antipsychotic Agents; Biological Availability; Chromatography; Delayed-Action Preparations; F | 1984 |
Depot fluphenazine: risk/benefit ratio.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Fe | 1984 |
Depot fluphenazine: risk/benefit ratio.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Fe | 1984 |
The use of depot neuroleptics: clinical experience in the United States.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Depressive Disorder; Drug Administration Sche | 1984 |
The use of depot neuroleptics: clinical experience in the United States.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Depressive Disorder; Drug Administration Sche | 1984 |
Antipsychotic drug side effects: their relationship to dose.
Topics: Agranulocytosis; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Dose-Respon | 1985 |
Antipsychotic drug side effects: their relationship to dose.
Topics: Agranulocytosis; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Dose-Respon | 1985 |
Low-dose treatment strategies.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, | 1986 |
Low-dose treatment strategies.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, | 1986 |
11 trials available for fluphenazine depot and Psychotic Disorders
| Article | Year |
|---|---|
Depot fluphenazine: risk/benefit ratio.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Fe | 1984 |
Depot fluphenazine: risk/benefit ratio.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Fe | 1984 |
The use of depot neuroleptics: clinical experience in the United States.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Depressive Disorder; Drug Administration Sche | 1984 |
The use of depot neuroleptics: clinical experience in the United States.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Depressive Disorder; Drug Administration Sche | 1984 |
Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trial.
Topics: Adult; Antipsychotic Agents; Benztropine; Delayed-Action Preparations; Depressive Disorder; Double-B | 1994 |
Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trial.
Topics: Adult; Antipsychotic Agents; Benztropine; Delayed-Action Preparations; Depressive Disorder; Double-B | 1994 |
Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks.
Topics: Adult; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Fluph | 1999 |
Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks.
Topics: Adult; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Fluph | 1999 |
Lithium augmentation fails to reduce symptoms in poorly responsive schizophrenic outpatients.
Topics: Ambulatory Care; Brief Psychiatric Rating Scale; Drug Therapy, Combination; Fluphenazine; Humans; Li | 1999 |
Lithium augmentation fails to reduce symptoms in poorly responsive schizophrenic outpatients.
Topics: Ambulatory Care; Brief Psychiatric Rating Scale; Drug Therapy, Combination; Fluphenazine; Humans; Li | 1999 |
Neuroleptic dose reduction in persistently psychotic patients.
Topics: Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluph | 1989 |
Neuroleptic dose reduction in persistently psychotic patients.
Topics: Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluph | 1989 |
Imipramine-responsive panic-like symptomatology in schizophrenia/schizoaffective disorder.
Topics: Adult; Benztropine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fear; | 1989 |
Imipramine-responsive panic-like symptomatology in schizophrenia/schizoaffective disorder.
Topics: Adult; Benztropine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fear; | 1989 |
Antipsychotic drug side effects: their relationship to dose.
Topics: Agranulocytosis; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Dose-Respon | 1985 |
Antipsychotic drug side effects: their relationship to dose.
Topics: Agranulocytosis; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Dose-Respon | 1985 |
Low-dose treatment strategies.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, | 1986 |
Low-dose treatment strategies.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, | 1986 |
Postpsychotic depression and negative symptoms: an investigation of syndromal overlap.
Topics: Adolescent; Adult; Aged; Benztropine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Me | 1988 |
Postpsychotic depression and negative symptoms: an investigation of syndromal overlap.
Topics: Adolescent; Adult; Aged; Benztropine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Me | 1988 |
Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination | 1987 |
Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination | 1987 |
31 other studies available for fluphenazine depot and Psychotic Disorders
| Article | Year |
|---|---|
Va'a fakalelei 'atamai: restoring the mind in the Kingdom of Tonga.
Topics: Fluphenazine; Kava; Mental Health Services; Psychotic Disorders; Tonga | 2014 |
Va'a fakalelei 'atamai: restoring the mind in the Kingdom of Tonga.
Topics: Fluphenazine; Kava; Mental Health Services; Psychotic Disorders; Tonga | 2014 |
Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Sch | 2009 |
Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Sch | 2009 |
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relati | 2010 |
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relati | 2010 |
The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Delayed-Action Preparations; Dose | 2002 |
The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Delayed-Action Preparations; Dose | 2002 |
Management of psychosis in Australian general practice.
Topics: Adolescent; Adult; Age Factors; Aged; Antimanic Agents; Antipsychotic Agents; Australia; Benzodiazep | 2006 |
Management of psychosis in Australian general practice.
Topics: Adolescent; Adult; Age Factors; Aged; Antimanic Agents; Antipsychotic Agents; Australia; Benzodiazep | 2006 |
[Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
Topics: Adult; Antipsychotic Agents; Dibenzothiepins; Double-Blind Method; Female; Fluphenazine; Humans; Mal | 1982 |
[Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
Topics: Adult; Antipsychotic Agents; Dibenzothiepins; Double-Blind Method; Female; Fluphenazine; Humans; Mal | 1982 |
The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
Topics: Administration, Oral; Antipsychotic Agents; Basal Ganglia Diseases; Biological Availability; Chronic | 1984 |
The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
Topics: Administration, Oral; Antipsychotic Agents; Basal Ganglia Diseases; Biological Availability; Chronic | 1984 |
[Clinical experience with depot neuroleptic treatment].
Topics: Female; Fluphenazine; Hallucinations; Humans; Male; Prognosis; Psychotic Disorders; Schizophrenia; S | 1984 |
[Clinical experience with depot neuroleptic treatment].
Topics: Female; Fluphenazine; Hallucinations; Humans; Male; Prognosis; Psychotic Disorders; Schizophrenia; S | 1984 |
Lithium versus fluphenazine for prophylaxis in mainly schizophrenic schizo-affectives.
Topics: Adolescent; Adult; Double-Blind Method; Drug Therapy, Combination; Fluphenazine; Humans; Lithium; Mi | 1984 |
Lithium versus fluphenazine for prophylaxis in mainly schizophrenic schizo-affectives.
Topics: Adolescent; Adult; Double-Blind Method; Drug Therapy, Combination; Fluphenazine; Humans; Lithium; Mi | 1984 |
[Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)].
Topics: Adult; Aged; Ambulatory Care; Delayed-Action Preparations; Female; Fluphenazine; Humans; Male; Middl | 1982 |
[Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)].
Topics: Adult; Aged; Ambulatory Care; Delayed-Action Preparations; Female; Fluphenazine; Humans; Male; Middl | 1982 |
Daytime variation in serum prolactin level in patients receiving oral and depot antipsychotic medication.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Female; Fluphenazine; Humans; Male; Prolactin; Psychotic Di | 1981 |
Daytime variation in serum prolactin level in patients receiving oral and depot antipsychotic medication.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Female; Fluphenazine; Humans; Male; Prolactin; Psychotic Di | 1981 |
[Results of treatment by Moditen Depot in outpatients' wards in the South Moravian Region (author's transl)].
Topics: Ambulatory Care; Delayed-Action Preparations; Fluphenazine; Humans; Psychotic Disorders | 1980 |
[Results of treatment by Moditen Depot in outpatients' wards in the South Moravian Region (author's transl)].
Topics: Ambulatory Care; Delayed-Action Preparations; Fluphenazine; Humans; Psychotic Disorders | 1980 |
Spiramycin-associated acute dystonia during neuroleptic treatment.
Topics: Adult; Anti-Bacterial Agents; Antipsychotic Agents; Delayed-Action Preparations; Drug Therapy, Combi | 1997 |
Spiramycin-associated acute dystonia during neuroleptic treatment.
Topics: Adult; Anti-Bacterial Agents; Antipsychotic Agents; Delayed-Action Preparations; Drug Therapy, Combi | 1997 |
Lowest effective dose of depot neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationsh | 1992 |
Lowest effective dose of depot neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationsh | 1992 |
Facial dyskinesia: a 16-year follow-up study.
Topics: Affective Disorders, Psychotic; Aged; Antipsychotic Agents; Brain; Chlorpromazine; Dose-Response Rel | 1991 |
Facial dyskinesia: a 16-year follow-up study.
Topics: Affective Disorders, Psychotic; Aged; Antipsychotic Agents; Brain; Chlorpromazine; Dose-Response Rel | 1991 |
Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration.
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Fluphenazine; Haloperidol; Humans; Injections, In | 1990 |
Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration.
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Fluphenazine; Haloperidol; Humans; Injections, In | 1990 |
Two cases of agranulocytosis on addition of a butyrophenone to a long-standing course of phenothiazine treatment.
Topics: Agranulocytosis; Antipsychotic Agents; Chlorpromazine; Clomipramine; Depressive Disorder; Dose-Respo | 1989 |
Two cases of agranulocytosis on addition of a butyrophenone to a long-standing course of phenothiazine treatment.
Topics: Agranulocytosis; Antipsychotic Agents; Chlorpromazine; Clomipramine; Depressive Disorder; Dose-Respo | 1989 |
Trials of adjunctive alprazolam in "negative symptom" patients.
Topics: Adult; Alprazolam; Depressive Disorder; Drug Therapy, Combination; Fluphenazine; Hallucinations; Hum | 1989 |
Trials of adjunctive alprazolam in "negative symptom" patients.
Topics: Adult; Alprazolam; Depressive Disorder; Drug Therapy, Combination; Fluphenazine; Hallucinations; Hum | 1989 |
Adjunctive imipramine maintenance treatment in schizophrenic patients with remitted postpsychotic depression.
Topics: Adult; Benztropine; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Fluphenazin | 1989 |
Adjunctive imipramine maintenance treatment in schizophrenic patients with remitted postpsychotic depression.
Topics: Adult; Benztropine; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Fluphenazin | 1989 |
Selection of neuroleptic dosage.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; | 1985 |
Selection of neuroleptic dosage.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; | 1985 |
Tardive dyskinesia and current dose of neuroleptic drugs.
Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixo | 1985 |
Tardive dyskinesia and current dose of neuroleptic drugs.
Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixo | 1985 |
Depot neuroleptics for acutely psychotic patients.
Topics: Acute Disease; Antipsychotic Agents; Fluphenazine; Haloperidol; Humans; Psychotic Disorders | 1987 |
Depot neuroleptics for acutely psychotic patients.
Topics: Acute Disease; Antipsychotic Agents; Fluphenazine; Haloperidol; Humans; Psychotic Disorders | 1987 |
[Tardive dystonia--a case report on therapy and metaphylaxis].
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Fluphena | 1988 |
[Tardive dystonia--a case report on therapy and metaphylaxis].
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Fluphena | 1988 |
Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression.
Topics: Benztropine; Depressive Disorder; Drug Therapy, Combination; Fluphenazine; Humans; Imipramine; Psych | 1988 |
Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression.
Topics: Benztropine; Depressive Disorder; Drug Therapy, Combination; Fluphenazine; Humans; Imipramine; Psych | 1988 |
Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
Topics: Adult; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Drug T | 1988 |
Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
Topics: Adult; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Drug T | 1988 |
Muscle pathology in the neuroleptic malignant syndrome.
Topics: Adult; Fluphenazine; Humans; Male; Muscles; Neuroleptic Malignant Syndrome; Procyclidine; Psychotic | 1987 |
Muscle pathology in the neuroleptic malignant syndrome.
Topics: Adult; Fluphenazine; Humans; Male; Muscles; Neuroleptic Malignant Syndrome; Procyclidine; Psychotic | 1987 |
Tardive dyskinesia complicated by hyperthyroidism.
Topics: Adult; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Psychotic Disorders; Thyrotoxicosis | 1987 |
Tardive dyskinesia complicated by hyperthyroidism.
Topics: Adult; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Psychotic Disorders; Thyrotoxicosis | 1987 |
Is postpsychotic depression a primary affective disorder?
Topics: Depressive Disorder; Fluphenazine; Humans; Psychotic Disorders; Schizophrenia | 1986 |
Is postpsychotic depression a primary affective disorder?
Topics: Depressive Disorder; Fluphenazine; Humans; Psychotic Disorders; Schizophrenia | 1986 |
[Depressive syndromes within the scope of schizophrenic psychoses].
Topics: Depressive Disorder; Fluphenazine; Hallucinations; Humans; Long-Term Care; Male; Models, Psychologic | 1985 |
[Depressive syndromes within the scope of schizophrenic psychoses].
Topics: Depressive Disorder; Fluphenazine; Hallucinations; Humans; Long-Term Care; Male; Models, Psychologic | 1985 |
Stability of the postpsychotic depression syndrome.
Topics: Adult; Depressive Disorder; Female; Fluphenazine; Humans; Male; Middle Aged; Outcome and Process Ass | 1986 |
Stability of the postpsychotic depression syndrome.
Topics: Adult; Depressive Disorder; Female; Fluphenazine; Humans; Male; Middle Aged; Outcome and Process Ass | 1986 |
Effects of smoking on fluphenazine clearance in psychiatric inpatients.
Topics: Adult; Female; Fluphenazine; Humans; Kinetics; Male; Metabolic Clearance Rate; Psychotic Disorders; | 1985 |
Effects of smoking on fluphenazine clearance in psychiatric inpatients.
Topics: Adult; Female; Fluphenazine; Humans; Kinetics; Male; Metabolic Clearance Rate; Psychotic Disorders; | 1985 |